diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/2072-0351-5646diaendo-5646Research ArticleСтатьиArticlesВозможно ли безопасное достижение целевого уровня гликированного гемоглобина при интенсивном режиме сахароснижающей терапии (по результатам исследования ADVANCE)Is it possible to achieve a safe glycated hemoglobin level during intensive hypoglycemic therapy? (results of ADVANCE study)ШестаковаМарина ВладимировнаShestakovaMarina Vladimirovna-ШамхаловаМинара ШамхаловнаShamkhalovaMinara Shamkhalovnashamkhalova@mail.ruФГУ Эндокринологический научный центр, МоскваEndocrinological Research Centre, Moscow201115062011142№2 (2011)110115Copyright © Шестакова М.В., Шамхалова М.Ш., 20112011Шестакова М.В., Шамхалова М.Ш.Shestakova M.V., Shamkhalova M.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/5646сахарный диабетгликлазид с модифицированным высвобождениемгликированный гемоглобининтенсивный контроль глюкозыисследование ADVANCEdiabetes mellitusglyclazide modified releaseglycated hemoglobinintensive blood glucose controlADVANCE studyReferencesIDF Diabetes Atlas, 4-H edition, 2009.IDF Diabetes Atlas, 4-H edition, 2009.Moss S.E., Klein R., Klein B.E., Meuer S.M. The association of glycaemia and cause-specific mortality in a diabetic population // Arch. Intern. Med. - 1994. - № 154. - Р. 22473-22479.Moss S.E., Klein R., Klein B.E., Meuer S.M. The association of glycaemia and cause-specific mortality in a diabetic population // Arch. Intern. Med. - 1994. - № 154. - Р. 22473-22479.Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study // BMJ. - 2000. - №152. - Р. 27-38.Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study // BMJ. - 2000. - №152. - Р. 27-38.Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., et al. Meta-analysis: glycosylated haemoglobin and cardiovascular disease in diabetes mellitus // Ann. Intern. Med. - 2004. - №141. - Р. 421-431.Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., et al. Meta-analysis: glycosylated haemoglobin and cardiovascular disease in diabetes mellitus // Ann. Intern. Med. - 2004. - №141. - Р. 421-431.Stettler C., Allemann S., Ju'' ni P., Cull C.A., Holman R.R., Egger M., et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials //Am. Heart. J. - 2006. - № 152. - Р. 27-38.Stettler C., Allemann S., Ju'' ni P., Cull C.A., Holman R.R., Egger M., et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials //Am. Heart. J. - 2006. - № 152. - Р. 27-38.Zoungas S., Ninomiya T., Patel A., Neal B., Colagiuri S., Heller S., et al. Association of glycaemic exposure with macrovascular and microvascular complications of type 2 diabetes: ADVANCE prospective observational analyses. // IDF 20th world diabetes congress Montreal; 2009 [abstract D-0690].Zoungas S., Ninomiya T., Patel A., Neal B., Colagiuri S., Heller S., et al. Association of glycaemic exposure with macrovascular and microvascular complications of type 2 diabetes: ADVANCE prospective observational analyses. // IDF 20th world diabetes congress Montreal; 2009 [abstract D-0690].Patel A., MacMahon S., Chalmers J., Neal B, Billot L., Woodward M., et al. Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes mellitus: results of the ADVANCE trial // N.Engl. J. Med. - 2008. - № 358. - Р. 2560-2572.Patel A., MacMahon S., Chalmers J., Neal B, Billot L., Woodward M., et al. Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes mellitus: results of the ADVANCE trial // N.Engl. J. Med. - 2008. - № 358. - Р. 2560-2572.UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) // Lancet. - 1998. - № 352. - Р. 837-853.UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) // Lancet. - 1998. - № 352. - Р. 837-853.VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes // N. Engl. J. Med. - 2009. - № 360. - Р. 129-139.VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes // N. Engl. J. Med. - 2009. - № 360. - Р. 129-139.Skyler J.S., Bergenstal R., Bonow O., Buse J., Deedwania P., Gale EAM, et al. Intensive glycemic control and the prevention of cardio - vascular events: implications of the ACCORD, ADVANCE and VD diabetes trials. A position statement of the ADA and a scientific state - ment of the ACC and the AHA // Diabetes Care. - 2009. - № 32. - Р. 187-192.Skyler J.S., Bergenstal R., Bonow O., Buse J., Deedwania P., Gale EAM, et al. Intensive glycemic control and the prevention of cardio - vascular events: implications of the ACCORD, ADVANCE and VD diabetes trials. A position statement of the ADA and a scientific state - ment of the ACC and the AHA // Diabetes Care. - 2009. - № 32. - Р. 187-192.Turnbull F., Abraira C., Anderson R.J., Byington R.P., Chalmers J.P., Duckworth WC, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes // Diabetologia. - 2009. - 52 . - P. 2288-2298.Turnbull F., Abraira C., Anderson R.J., Byington R.P., Chalmers J.P., Duckworth WC, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes // Diabetologia. - 2009. - 52 . - P. 2288-2298.Ray K.K., Seshasai S.R., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of patients randomized controlled trial // Lancet. - 2009. - № 373. - Р. 1765-1772.Ray K.K., Seshasai S.R., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of patients randomized controlled trial // Lancet. - 2009. - № 373. - Р. 1765-1772.The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effects of intensive glucose lowering in type 2 diabetes // N.Engl. J. Med. - 2008. - № 358. - Р. 2545-2559.The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effects of intensive glucose lowering in type 2 diabetes // N.Engl. J. Med. - 2008. - № 358. - Р. 2545-2559.
The authors declare that there are no conflicts of interest present.